Saidal, Swiss biotechnology group sign MoU

ALGIERS - The public pharmaceutical group Saidal signed a memorandum of understanding (MoU) with the Swiss group "Bioexpress Therapeutics," with a view to establishing a framework for cooperation in the fields of biotechnology, training, and skills development, according to a communiqué issued by the group on Monday.